@RBlancoMFyC Aquí por ej un metanálisis https://t.co/KtZH2XfnBA
RT @DanielJDrucker: To date the available data does not make a strong case for stand alone CV benefits #heartdisease of metformin, yet with…
RT @DanielJDrucker: To date the available data does not make a strong case for stand alone CV benefits #heartdisease of metformin, yet with…
RT @DanielJDrucker: To date the available data does not make a strong case for stand alone CV benefits #heartdisease of metformin, yet with…
RT @DanielJDrucker: To date the available data does not make a strong case for stand alone CV benefits #heartdisease of metformin, yet with…
RT @DanielJDrucker: To date the available data does not make a strong case for stand alone CV benefits #heartdisease of metformin, yet with…
To date the available data does not make a strong case for stand alone CV benefits #heartdisease of metformin, yet with limitations https://t.co/hdAQS6yIfT https://t.co/lULTMSKpkg
@tolquen @DocTotoscope Prendre les évènements CV me va parfait. https://t.co/oaKwu7MS9o et https://t.co/gnyCffHSYe et https://t.co/1LUofwD0QC et https://t.co/1bcvoDlSqR et https://t.co/Afau1268N5
@Caracolade @hugonocoque @DocTotoscope Diabetologia, BMJ, PlosOne, Diabetes & Metabolism, Cochrane : https://t.co/oaKwu7MkjQ ; https://t.co/gnyCffHl8G ; https://t.co/khJiV4Cjme ; https://t.co/1bcvoDlkBj ; https://t.co/oGQJbu2F5U : Pas de bénéfice car
@biorxivpreprint Metformn is frequently touted as being cardioprotective in animal studies, and based on some retrospective non-randomized trials. It is more difficult to support this claim from analyses of human RCTs https://t.co/SIk3gpqyTV https://t.co/h
These CV benefits observed in UKPDS have largely not been corroborated in subsequent randomised trials, or meta-analyses of these trials https://t.co/9VB3yka8xk
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @jaimeamorvalero: Para mi es mas que neutra... los #clasicos seran clasicos siempre y la Metformina sigue siendo el catalizador metaboli…
Totalmente de acuerdo Interesante revisión.
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
Impacto de la metformina en la enfermedad cardiovascular: un metanálisis de ensayos aleatorios entre personas con diabetes tipo 2 https://t.co/PQhWpvGwGM
RT @drleonjimenez: Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiend…
Para mi es mas que neutra... los #clasicos seran clasicos siempre y la Metformina sigue siendo el catalizador metabolico en la mayoria de los DM
Para los detractores de la Metformina con todo mi cariño: https://t.co/pd2hlp8wTy Usamos DDPIV como rosquillas a sabiendas que son "neutros" pero nos olvidamos que es neutra también y mucho más barata y encima baja más la Hba1c....
RT @HecmagsMD: Metformin has a cardiovascular benefit...? This meta analysis says there’s no evidence: https://t.co/igOHGGHswX 🤔#Askingfor…
RT @HecmagsMD: Metformin has a cardiovascular benefit...? This meta analysis says there’s no evidence: https://t.co/igOHGGHswX 🤔#Askingfor…
RT @HecmagsMD: Metformin has a cardiovascular benefit...? This meta analysis says there’s no evidence: https://t.co/igOHGGHswX 🤔#Askingfor…
RT @HecmagsMD: Metformin has a cardiovascular benefit...? This meta analysis says there’s no evidence: https://t.co/igOHGGHswX 🤔#Askingfor…
RT @HecmagsMD: Metformin has a cardiovascular benefit...? This meta analysis says there’s no evidence: https://t.co/igOHGGHswX 🤔#Askingfor…
RT @HecmagsMD: Metformin has a cardiovascular benefit...? This meta analysis says there’s no evidence: https://t.co/igOHGGHswX 🤔#Askingfor…
Metformin has a cardiovascular benefit...? This meta analysis says there’s no evidence: https://t.co/igOHGGHswX 🤔#Askingforafriend #NKFClinicals https://t.co/qhNTQBgdY8
Interesting study to scrutinize the impact of metformin on cardiovascular disease. https://t.co/GHI9iupxTQ
RT @DanielJDrucker: Many #diabetes societies & colleagues believe #metformin should always and forever be first line Rxment #T2D Track reco…
RT @DanielJDrucker: Many #diabetes societies & colleagues believe #metformin should always and forever be first line Rxment #T2D Track reco…
Many #diabetes societies & colleagues believe #metformin should always and forever be first line Rxment #T2D Track record, efficacy, safety, price all compelling arguments. Some cite evidence that metformin reduces #CVD & #mortality The ice thins..
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. Impact of #metfor…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. Impact of #metfor…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. Impact of #metfor…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. Impact of #metfor…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. Impact of #metfor…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. Impact of #metfor…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. Impact of #metfor…
Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. Impact of #metformin on #cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes by Griffin, Leaver, Irving https://
RT @dranilUSW: A recent meta-analysis concludes that robust studies examining the effects of metformin on cardiovascular endpoints are lack…
A recent meta-analysis concludes that robust studies examining the effects of metformin on cardiovascular endpoints are lacking and in this analysis, the beneficial effects of metformin remain unclear. https://t.co/DIddT2MrAP
Impact of metformin: a meta-analysis of randomised trials among people with type 2 diabetes https://t.co/aLaK8Epejb
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
"There remains uncertainty about whether metformin reduces risk of cardiovascular disease among patients with #T2D". https://t.co/MZ0cJDeotY
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
#EASD2016 Lisboa https://t.co/LZuWSkNA0P
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
RT @DiabetologiaJnl: Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co…
Impact of #metformin on #cardiovasculardisease: meta-analysis of randomised trials among people with #T2D https://t.co/tNvHT8NhUT #EASD2017
RT @DiabetologiaJnl: Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with T2D https://t.co…
RT @DiabetologiaJnl: Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with T2D https://t.co…
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with T2D https://t.co/tNvHT94SMr
RT @DiabetologiaJnl: Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with T2D https://t.co…
RT @DiabetologiaJnl: Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with T2D https://t.co…
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with T2D https://t.co/tNvHT94SMr
RT @profsmarshall: Upfront & free to read in Sept @DiabetologiaJnl: Impact of metformin on cardiovascular disease https://t.co/R7YjOPm3Ao
RT @profsmarshall: Upfront & free to read in Sept @DiabetologiaJnl: Impact of metformin on cardiovascular disease https://t.co/R7YjOPm3Ao
Upfront & free to read in Sept @DiabetologiaJnl: Impact of metformin on cardiovascular disease https://t.co/R7YjOPm3Ao
RT @PCU_Cambridge: ...and here is the paper https://t.co/ceZR2HjXy9 https://t.co/P7bqasxo3K
RT @PCU_Cambridge: ...and here is the paper https://t.co/ceZR2HjXy9 https://t.co/P7bqasxo3K
...and here is the paper https://t.co/a9G099sxJK https://t.co/LE04xmJDVl
...and here is the paper https://t.co/ceZR2HjXy9 https://t.co/P7bqasxo3K
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with T2D https://t.co/tNvHT8NhUT
Impact of metformin on cardiovascular disease - type 2 diabetes https://t.co/wn0rtf7OSl
Meta-analysis of RCTs. Metformin, 1st-line drug in T2D, causes neither benefit nor harm in terms CVD events https://t.co/UzG5dhvYwR
Impact of metformin on cardiovascular disease: Meta-analysis of RCTs among people w/type 2 diabetes https://t.co/c1eAu6dEyU #PublicHealth
Impact of metformin on cardiovascular disease: Meta-analysis of RCTs among people w/type 2 diabetes https://t.co/mZggyVgpaa #PublicHealth
@JMedInternetRes Impact of metformin on #CardiovascularDisease: a... https://t.co/Jn4Juvn3qh via springer https://t.co/XsvNxEs6H1
RT @MRCEpiPrevent: Special issue of Diabetologia on #metformin includes our systematic review of impact on CVD in people with #diabetes htt…
Special issue of Diabetologia on #metformin includes our systematic review of impact on CVD in people with #diabetes https://t.co/yn9ChpmtSn https://t.co/mNlm0UJauR